ROH-001 ophthalmic solution phase II clinical trial in patients with myopia
Recruiting
- Conditions
- Myopia
- Registration Number
- jRCT2031250015
- Lead Sponsor
- ROHTO Pharmaceutical Co., Ltd.
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 210
Inclusion Criteria
Written informed consent from subjects guardian or legally acceptable representative have been obtained Cycloplegic objective spherical equivalent <=-1.50 D, >-6.00 D in both eyes Patients with progressive myopia
Exclusion Criteria
Patients who previously receive treatments for slowing myopia progression. Patients who the principal/sub investigator has determined are not suitable to participate in this study
Study & Design
- Study Type
- Interventional
- Study Design
- parallel assignment
- Primary Outcome Measures
Name Time Method - The change in objective spherical equivalent
- Secondary Outcome Measures
Name Time Method